Extracellular matrix in the tumor microenvironment and its impact on cancer therapy

E Henke, R Nandigama, S Ergün - Frontiers in molecular biosciences, 2020 - frontiersin.org
Solid tumors are complex organ-like structures that consist not only of tumor cells but also of
vasculature, extracellular matrix (ECM), stromal, and immune cells. Often, this tumor …

The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?

A Jurj, C Ionescu, I Berindan-Neagoe… - Journal of Experimental & …, 2022 - Springer
The extracellular matrix (ECM) is an important component of the tumor microenvironment
(TME), having several important roles related to the hallmarks of cancer. In cancer, multiple …

Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapy

H Hua, Q Kong, J Yin, J Zhang, Y Jiang - Journal of hematology & …, 2020 - Springer
Insulin-like growth factors (IGFs) play important roles in mammalian growth, development,
aging, and diseases. Aberrant IGFs signaling may lead to malignant transformation and …

The drug-induced phenotypic landscape of colorectal cancer organoids

J Betge, N Rindtorff, J Sauer, B Rauscher… - Nature …, 2022 - nature.com
Patient-derived organoids resemble the biology of tissues and tumors, enabling ex vivo
modeling of human diseases. They have heterogeneous morphologies with unclear …

FAK structure and regulation by membrane interactions and force in focal adhesions

P Tapial Martínez, P López Navajas, D Lietha - Biomolecules, 2020 - mdpi.com
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase with key roles in the
regulation of cell adhesion migration, proliferation and survival. In cancer FAK is a major …

The extracellular matrix in pancreatic cancer: description of a complex network and promising therapeutic options

B Ferrara, C Pignatelli, M Cossutta, A Citro, J Courty… - Cancers, 2021 - mdpi.com
Simple Summary This review depicts the principal mechanisms involved in the process of
stromal desmoplasia characterizing pancreatic ductal adenocarcinoma (PDAC). The aim of …

[HTML][HTML] Overcoming adaptive resistance to KRAS and MEK inhibitors by co-targeting mTORC1/2 complexes in pancreatic cancer

WS Brown, PC McDonald, O Nemirovsky, S Awrey… - Cell Reports …, 2020 - cell.com
Activating KRAS mutations are found in over 90% of pancreatic ductal adenocarcinomas
(PDACs), yet KRAS has remained a difficult target to inhibit pharmacologically. Here, we …

mTORC1, the maestro of cell metabolism and growth

L He, S Cho, J Blenis - Genes & Development, 2025 - genesdev.cshlp.org
The mechanistic target of rapamycin (mTOR) pathway senses and integrates various
environmental and intracellular cues to regulate cell growth and proliferation. As a key …

mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching

S Shin, MJ Han, MP Jedrychowski, Z Zhang… - Cell reports, 2023 - cell.com
Cells maintain and dynamically change their proteomes according to the environment and
their needs. Mechanistic target of rapamycin (mTOR) is a key regulator of proteostasis …

Targeting AKT/PKB to improve treatment outcomes for solid tumors

M Iida, PM Harari, DL Wheeler, M Toulany - … Research/Fundamental and …, 2020 - Elsevier
The serine/threonine kinase AKT, also known as protein kinase B (PKB), is the major
substrate to phosphoinositide 3-kinase (PI3K) and consists of three paralogs: AKT1 (PKBα) …